 NEW PRAGUE, Minn.--BUSINESS WIRE--Electromed, Inc. Electromed or the Company NYSE American: ELMD, a leader in innovative airway clearance technologies, today announced that its Board of Directors has approved a 3.0 million stock repurchase authorization, effective as of May 26, 2021. Under the authorization, the Company may repurchase common stock, par value 0.01 per share, with an aggregate value of up to 3.0 million through May 26, 2022. The authorization does not obligate the Co 